The omission rates of CRC in negative patients in the high-risk and physical examination groups in this study were 5.10% and 3.40%, respectively, and it is presumed that SDC2 gene expression was lower, or methylation was not expressed in certain sources of intestinal cancer [24], which needs to be demonstrated in further studies. This evidence concerns the gene SDC2 and intestinal cancer.